mRNA Vaccines Beyond COVID-19: Emerging Therapeutic Frontiers

Abstract

The rapid development and deployment of mRNA vaccines during the COVID-19 pandemic represented a pivotal moment in medical science, emphasizing the technology's potential far beyond its initial applications. As researchers explore the versatility of mRNA platforms further, the possibility of expanding their use to tackle a wide range of health challenges is becoming increasingly feasible. This study aims to encompassing diverse areas such as infectious diseases, personalized medicine, oncology, and chronic infections like HIV and tuberculosis. The inherent adaptability of mRNA technology, characterized by its ability to be quickly customized in response to emerging pathogens, establishes it as a critical tool for frontline pandemic defense and a powerful approach to personalized cancer immunotherapy. Consequently, the ongoing advancement of mRNA vaccine development holds immense promise for revolutionizing therapeutic strategies across various medical fields.